- Home
- CRVO vs DTSQ Comparison
CRVO vs DTSQ Comparison
Compare CRVO & DTSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- DTSQ
- Stock Information
- Founded
- CRVO 2001
- DTSQ 2022
- Country
- CRVO United States
- DTSQ United States
- Employees
- CRVO N/A
- DTSQ N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- DTSQ
- Sector
- CRVO Health Care
- DTSQ
- Exchange
- CRVO Nasdaq
- DTSQ NYSE
- Market Cap
- CRVO 95.4M
- DTSQ 90.9M
- IPO Year
- CRVO N/A
- DTSQ 2024
- Fundamental
- Price
- CRVO $8.91
- DTSQ $10.24
- Analyst Decision
- CRVO Strong Buy
- DTSQ
- Analyst Count
- CRVO 8
- DTSQ 0
- Target Price
- CRVO $25.43
- DTSQ N/A
- AVG Volume (30 Days)
- CRVO 13.3M
- DTSQ 2.1K
- Earning Date
- CRVO 03-17-2025
- DTSQ 01-01-0001
- Dividend Yield
- CRVO N/A
- DTSQ N/A
- EPS Growth
- CRVO N/A
- DTSQ N/A
- EPS
- CRVO N/A
- DTSQ 0.17
- Revenue
- CRVO $9,737,974.00
- DTSQ N/A
- Revenue This Year
- CRVO N/A
- DTSQ N/A
- Revenue Next Year
- CRVO N/A
- DTSQ N/A
- P/E Ratio
- CRVO N/A
- DTSQ $61.53
- Revenue Growth
- CRVO 36.29
- DTSQ N/A
- 52 Week Low
- CRVO $1.80
- DTSQ $9.96
- 52 Week High
- CRVO $25.92
- DTSQ $10.37
- Technical
- Relative Strength Index (RSI)
- CRVO 63.30
- DTSQ N/A
- Support Level
- CRVO $8.53
- DTSQ N/A
- Resistance Level
- CRVO $16.94
- DTSQ N/A
- Average True Range (ATR)
- CRVO 2.01
- DTSQ 0.00
- MACD
- CRVO 0.66
- DTSQ 0.00
- Stochastic Oscillator
- CRVO 50.33
- DTSQ 0.00
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About DTSQ DT CLOUD STAR ACQUISITION CORP
DT Cloud Star Acquisition Corp is a blank check company.